会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • SELF-ASSEMBLING MODULAR PERCUTANEOUS VALVE AND METHODS OF FOLDING, ASSEMBLY AND DELIVERY
    • 自组装模块式阀门及折叠,组装和运输方法
    • WO2011086401A1
    • 2011-07-21
    • PCT/IB2010/000049
    • 2010-01-13
    • VALVE MEDICAL LTDRICHTER, YoramRICHTER, JacobWEISZ, Ety
    • RICHTER, YoramRICHTER, JacobWEISZ, Ety
    • A61F2/24
    • A61F2/2415A61F2/24A61F2/2406A61F2/2409A61F2/2412A61F2/2418A61F2/2427A61F2/844A61F2210/0014A61F2230/0091A61F2250/006
    • The present invention provides a modular prosthetic valve device designed as two or more device modules that may be delivered to a body lumen unassembled and then assembled into the assembled valve device in the body at least in part using a self-assembly member at or near the site of valve implantation. The device modules may include a support structure and a valve module. The valve module may be delivered in an unassembled, folded delivery configuration, and unfolded and assembled into a working configuration via the self-assembly member. In its unassembled form, the valve module may be a single-piece leaflets substructure or a plurality of valve sections. The self-assembly member has a delivery configuration and a preset configuration, and may be triggered to revert to the preset configuration to assemble the valve module. The modular valve device may be folded in a manner not possible with current valve devices, for example, by rolling the unassembled valve module along its circumferential axis in the direction of its height, so that the diameter of the folded valve module may be equivalent to that of one rolled leaflet. This feature of the invention provides a percutaneous valve device having a smaller delivery diameter than pre-assembled valve devices. This in turn permits use of a delivery device of reduced diameter and increases the flexibility of the loaded delivery device compared to percutaneous valve devices in the art. The invention further provides a system for and method of folding and delivering such a modular valve device and assembling it using the self-assembly member, preferably in the body.
    • 本发明提供了一种设计为两个或更多个装置模块的模块化假体瓣膜装置,其可以被输送到未被组装的身体腔体,然后至少部分地使用位于或靠近该组件的自组装构件 瓣膜植入部位。 装置模块可以包括支撑结构和阀模块。 阀模块可以以未组装的折叠输送构造递送,并且经由自组装构件展开并组装成工作构型。 在其组装形式中,阀模块可以是单件式叶片子结构或多个阀部分。 自组装构件具有输送配置和预设配置,并且可以被触发以恢复到预设配置以组装阀模块。 模块化阀装置可以以当前阀装置不可能的方式进行折叠,例如通过沿着其周向轴线在其高度方向上滚动未组装的阀模块,使得折叠的阀模块的直径可以等于 一个滚动的小叶。 本发明的该特征提供了一种具有比预组装阀装置更小的输送直径的经皮瓣膜装置。 这又允许使用减小直径的输送装置,并且与本领域中的经皮瓣膜装置相比增加了装载的输送装置的灵活性。 本发明还提供了一种用于折叠和传送这种模块化阀装置的系统和方法,并且使用自组装构件优选地在身体中组装它。
    • 7. 发明申请
    • METHOD OF TREATING ACUTE CORONARY SYNDROMES
    • 治疗急性冠状动脉综合征的方法
    • WO2005002545A8
    • 2006-02-16
    • PCT/US2004020487
    • 2004-06-24
    • BIOREST LTDRICHTER YORAMEDELMAN ELAZER RGOLOMB GERSHONDANENBERG HAIM D
    • EDELMAN ELAZER RGOLOMB GERSHONDANENBERG HAIM D
    • A61K31/663A61K9/127
    • A61K31/663
    • The present invention relates to methods and compositions designed for the treatment or management of acute coronary syndromes, particularly, unstable angina and acute myocardial infarction. The methods of the invention comprise the administration of an effective amount of a formulation containing one or more therapeutic agents which specifically decreases or inhibits the activity of phagocytic cells and/or eliminates or diminishes the amount of phagocytic cells including, but not limited to, macrophages and monocytes. The formulations are specifically targeted to phagocytic cells. The invention also provides pharmaceutical compositions of formulations containing one or more therapeutic agents of the invention for administration to subjects currently suffering from or having recently suffered an acture coronary syndrome such as unstable angina and acute myocardial infarction.
    • 本发明涉及设计用于治疗或治疗急性冠状动脉综合征,特别是不稳定性心绞痛和急性心肌梗塞的方法和组合物。 本发明的方法包括施用有效量的含有一种或多种治疗剂的制剂,其特异性降低或抑制吞噬细胞的活性和/或消除或减少吞噬细胞的量,包括但不限于巨噬细胞 和单核细胞。 制剂专门针对吞噬细胞。 本发明还提供了含有本发明的一种或多种治疗剂的制剂的药物组合物,用于给予目前患有或最近患有冠状动脉综合征如不稳定型心绞痛和急性心肌梗死的受试者。